Promises made, promises kept: Alnylam CEO John Maraganore adds 3rd straight positive pivotal as he aims at another new drug OK

Alnylam CEO John Maraganore has been keeping his promises this year.

Following the historic first OK for an RNAi drug last year, the crew at …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Promis­es made, promis­es kept: Al­ny­lam CEO John Maraganore adds 3rd straight pos­i­tive piv­otal as he aims at an­oth­er new drug OK